ATE246243T1

Oxygen activatable formulations for disinfection or sterilization

Abstract

Methods and compositions are disclosed for producing air-activated, i.e., oxygen (O2) activated, disinfectant-sterilent solutions. Solutions containing a haloperoxidase (i.e., a halide:hydrogen peroxide (H2O2) oxidoreductase, such as myeloperoxidase, eosinophil peroxidase or lactoperoxidase) plus a halide or combination of halides (i.e., chloride, bromide and/or iodide), an oxidase (i.e., a substrate:O2 oxidoreductase) capable of generating H2O2, and a substrate specific for that oxidase, are separately prepared under aerobic conditions, but all of the component solutions are made anaerobic prior to final combination and mixing. The anaerobic formulations are dispensed into containers capable of maintaining the anaerobic condition (e.g., pressurized canisters). Dispensing the solution at the time of use exposes the formulation to air (i.e., O2) which activates its disinfectant-sterilent properties. O2 is the rate limiting component for oxidase generation of H2O2. Under aerobic conditions the oxidase catalyzes the oxidation of its substrate and the reduction of O2 to generate H2O2. In turn, H2O2 serves as substrate for haloperoxidase which catalyzes the oxidation of halide to hypohalous acid. Hypohalous acid reacts with an additional H2O2 to generate singlet molecular oxygen (1O2). Hypohalous acid (e.g., hypochlorous acid) and especially 1O2 are potent microbicidal agents. Both haloperoxidase generation of hypohalous acid and its reactive consumption to yield 1O2 are dependent on the availability of H2O2. A high rate of H2O2 generation does not result in the accumulation of hypohalous acid, but instead results in a high rate of 1O2 production. The microbicidal capacity and toxicity of 1O2 are limited by the half-life of this metastable electronically excited reactant, and as such, disinfectant-sterilent activity is temporally defined by and confined to the dynamics of oxidant generation. The disinfectant-sterilent activity of formulation requires air exposure and is dependent on the presence of the halide-haloperoxidase combination employed, the activity of the oxidase present, the availability of oxidase-specific substrate and the availability of O2.

Term

Term ended

Projected expiry passed 9 May 2016, 10.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

84 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
45752495United States of AmericaA
9606687United States of AmericaW

Members84

Family members, oldest first
DocumentOfficeKind
CA2061601A1CanadaA1
EP0500387A2European Patent Office (EPO)A2
IE920514A1IrelandA1
WO9214484A1World Intellectual Property Organization (WIPO)A1
AU1536492AAustraliaA
EP0500387A3European Patent Office (EPO)A3
IL100997D0IsraelD0
KR930703012ARepublic of KoreaA
JPH06505482AJapanA
CA2158576A1CanadaA1
WO9423742A1World Intellectual Property Organization (WIPO)A1
AU6697194AAustraliaA
CA2167525A1CanadaA1
WO9504135A1World Intellectual Property Organization (WIPO)A1
US5389369AUnited States of AmericaA
AU7477294AAustraliaA
US5451402AUnited States of AmericaA
AU663869B2AustraliaB2
EP0693934A1European Patent Office (EPO)A1
KR960701656ARepublic of KoreaA
US5510104AUnited States of AmericaA
EP0713527A1European Patent Office (EPO)A1
CN1128044AChinaA
IL100997AIsraelA
US5565197AUnited States of AmericaA
JPH08511001AJapanA
CA2222964A1CanadaA1
WO9638548A1World Intellectual Property Organization (WIPO)A1
AU5740196AAustraliaA
JPH09503752AJapanA
AU679777B2AustraliaB2
AU684505B2AustraliaB2
EP0713527A4European Patent Office (EPO)A4
US5718896AUnited States of AmericaA
EP0832198A1European Patent Office (EPO)A1
US5756090AUnited States of AmericaA
KR19990022188ARepublic of KoreaA
US5888505AUnited States of AmericaA
JPH11506444AJapanA
EP0923939A1European Patent Office (EPO)A1
EP0500387B1European Patent Office (EPO)B1
AT181837TAustriaT
ATE181837T1AustriaT1
AU708557B2AustraliaB2
DE69229512D1GermanyD1
US6033662AUnited States of AmericaA
DE69229512T2GermanyT2
IE20000984A1IrelandA1
US6294168B1United States of AmericaB1
EP0713527B1European Patent Office (EPO)B1
AT208563TAustriaT
ATE208563T1AustriaT1
KR100306968B1Republic of KoreaB1
DK0713527T3DenmarkT3
DE69429094D1GermanyD1
EP0832198A4European Patent Office (EPO)A4
DE69429094T2GermanyT2
CN1081672CChinaC
KR100325901B1Republic of KoreaB1
EP0693934B1European Patent Office (EPO)B1
AT225667TAustriaT
ATE225667T1AustriaT1
DE69431519D1GermanyD1
US6503507B1United States of AmericaB1
DE69431519T2GermanyT2
CA2061601CCanadaC
EP0832198B1European Patent Office (EPO)B1
AT246243TAustriaT
ATE246243T1This recordAustriaT1
DE69629296D1GermanyD1
DE69629296T2GermanyT2
JP2004300157AJapanA
KR100449283B1Republic of KoreaB1
JP3723209B2JapanB2
CA2167525CCanadaC
JP2007051153AJapanA
EP0923939B1European Patent Office (EPO)B1
AT365048TAustriaT
ATE365048T1AustriaT1
DE69233698D1GermanyD1
CA2158576CCanadaC
DE69233698T2GermanyT2
JP4063317B2JapanB2
CA2222964CCanadaC